pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Teva on the hunt for new R&D head; Summit's rejection came after commercial chief's exit

Nov 20, 2026·read at Endpoints ↗

→ Teva’s global R&D leader and CMO Eric Hughes has stepped down and David Gardiner is replacing him on an interim basis. Hughes came to Teva in 2022 from Vertex, where he was SVP of ...

source

Reporting by Endpoints.

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 34m agoCelldex culls eczema study after Phase 2 failureEndpoints
  • 59m agoCNS dispatches from Jefferies: Acadia’s search for deals, Alto’s psychiatry question and ProMIS’ Alzheimer’s ambitionsEndpoints
  • 17h agoCongressional biotech commission warns of China deal flowEndpoints
  • 17h agoSanofi's Infilbray wins first approval for neurological symptoms of GaucherEndpoints
  • 20h agoLilly starts work on Pennsylvania obesity plant; ITM, AtomVie strike supply dealEndpoints